Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Episode 5 July 07, 2021 00:51:14
Episode 5:  Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc
Few & Far Between: How Biotech Gets Built
Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Jul 07 2021 | 00:51:14

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

Other Episodes

Episode 60

September 17, 2025 00:42:11
Episode Cover

Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Can AI see and talk to human cells? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien...

Listen

Episode 34

October 10, 2023 00:44:45
Episode Cover

Episode 34: Dan Mandell, CEO at GRO Biosciences

"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....

Listen

Episode 14

November 10, 2021 00:46:16
Episode Cover

Episode 14: Bo Bigelow, Chairman at the Foundation for USP7-Related Diseases, and Trish Flanagan, President at the Yellow Brick Road Project

How will a rare disease diagnosis affect your family? Today's Few & Far Between episode features Bo Bigelow, Chairman at the Foundation for USP7-Related...

Listen